Diarrhoea induced by chemotherapy in cancer patients is common, causes notable
morbidity and mortality, and is managed inconsistently. Previous management guidelines …

Chemotherapy-induced diarrhea (CID) is a common and often severe side effect
experienced by colorectal cancer (CRC) patients during their treatment. As chemotherapy …

Background & aims Radical radiation therapy is commonly used for treatment of pelvic
cancer. Up to 80% of patients receiving radiotherapy will develop acute radiation induced …

Chemotherapy-induced diarrhoea (CID) is a common side-effect experienced by patients
being treated with a variety of antineoplastic agents. Approximately 80% of patients …

Chemotherapy for cancer causes significant gut toxicity, leading to severe clinical
manifestations and an increased economic burden. Despite much research, many of the …

Chemotherapy services in the UK have been the subject of national policy directives for the
past decade. These directives, amongst other things, include the development of nurse-led …

Background and Purpose Intestinal mucositis is a common side‐effect of irinotecan‐based
cancer chemotherapy regimens. This mucositis is associated with cytokine activation and …

Abstract Background The antimetabolite chemotherapy 5-Fluorouracil is one of the most
commonly prescribed drugs in clinical cancer treatment. Although this drug is not specific for …

Background: Analysis of relative importance of side effects of anticancer therapy is extremely
useful in the process of clinical decision making. There is evidence that patients' perception …

Objective: The effects of combined oxycodone/naloxone prolonged release tablets (OXN
PR) were investigated in patients with moderate-to-severe chronic cancer-related or non …